
Medtronic plc is a global medical device and healthcare technology company founded in 1949, headquartered in Dublin, Ireland with operational headquarters in Minneapolis, Minnesota. Through its corporate ventures group, Medtronic invests in medical device, diagnostics, and digital health startups aligned with its strategic roadmap, with over $500 million in venture investments.
47% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Average disclosed round size is $56.2M (across 35 rounds with reported amounts).
Portfolio
30
Fund Size
—
Top Stage
Unknown
Last 12 Mo
2
Team
Kweli P. Thompson
Executive Vice President and President, Neuroscience Portfolio
Alex Gu
SVP & President, Greater China
Majid Kaddoumi
SVP & President, Europe, Middle East, Africa & Asia-Pacific (EurAsia)
Scott Cundy
SVP & Chief Quality, Development, & Innovation Officer
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| RRapidPulse, Inc. | Series B | $48M | Jul 2026 |
| CCereVasc, Inc. | Series C | $85M | Jun 2026 |
| Unknown | $100M | Jan 2026 | |
| CCereVasc, Inc. | Series C | $85M | Jan 2026 |
| RRapidPulse, Inc. | Series B | $48M | Jan 2026 |
| Unknown | $115M | Jan 2026 | |
| Series C | $100M | Mar 2025 | |
| Unknown | $120M | Jan 2025 | |
| Series C | $200M | Jan 2025 | |
| Series C | $22M | Feb 2024 | |
| Unknown | $25M | Mar 2023 | |
| Series B | $50M | Jul 2022 | |
| SScivita Medical | Series A | — | Jan 2021 |
| AAegea | Series C | $40M | Jan 2018 |
| Series C | $35M | Jun 2017 | |
| Growth | $35M | Jun 2017 | |
| Series C | $73M | Jun 2017 | |
| Growth | $35M | Jan 2017 | |
| Series B | $16.5M | Jan 2015 | |
| Series E | — | May 2014 | |
| TTwelve, Inc. | Unknown | $9.1M | Jan 2014 |
| Unknown | — | Jan 2012 | |
| Series C | $24M | Jul 2011 | |
| SSpinal Modulation | Series D | $30M | Jul 2011 |
| Unknown | $30M | Jan 2011 |
Top Co-Investors
Last updated: 7 October 2026